Carvykti’s Lead in Multiple Myeloma Reinforced by Strong Survival Data
Philadelphia, PA – In the field of multiple myeloma treatment, Johnson & Johnson and Legend Biotech are proving to be leaders with their strong showing in increasing survival rates for patients. The companies presented compelling data that solidified their positions in the race to combat this incurable cancer. The recent data revealed by Johnson & … Read more